Results

Total Results: 5,388 records

Showing results for "statistically significant".

  1. hcup-us.ahrq.gov/db/ccr/ed-ccr/EDCCR-UserGuide-2012-2019.pdf
    January 01, 2019 - EDCCR_UserGuide_2012-2019 USER GUIDE: COST-TO-CHARGE RATIO (CCR) FOR EMERGENCY DEPARTMENT FILES Issued October 2021 Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP) Phone: (866) 290-HCUP (4287) Email: hcup@ahrq.gov Website: www.hcup-us.ahrq.gov mailto:hcup@ahrq…
  2. hcup-us.ahrq.gov/db/ccr/ed-ccr/ED_CCR_User_Guide_External_2012-2022.pdf
    January 01, 2022 - User Guide: Cost-to-Charge Ratio for ED files, 2012-2022 USER GUIDE: COST-TO-CHARGE RATIO (CCR) FOR EMERGENCY DEPARTMENT FILES Issued May 2025 Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP) Phone: (866) 290-HCUP (4287) …
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - • One small crossover trial found no significant improvement in IRLS scores with dopamine agonist … Improvement was significant for gabapentin enacarbil therapy but not for pregabalin treatment (p=0.03 … Patients with severe RLS (38% denoted by an IRLS baseline score >20) showed significant reductions … There was an overall significant increase in study withdrawals due to adverse effects associated with … • Establish minimum important differences in scale scores that translate to clinically significant
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_cAa3AjFGQ2np_aQnzQGA
    February 11, 2025 - Wines, MPH; Meera Viswanathan, PhD IMPORTANCE Fragility fractures result in significant morbidity. … Compared with placebo, no statistically significant associations were observed for adverse events. … The pooled esti- mates for all fractures or osteoporotic fractures had similar ARDs but were not statisticallysignificant. … significant associations ob- served.
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wx_w92ukxeDvNShoRQXbhP
    September 06, 2016 - 0 vs 3 deaths in the placebo group; RR, 0.14 [95% CI, 0.01-2.78]), although this difference was not statisticallysignificant. … participants being treated with isoniazid than with placebo, although this finding was not sta- tistically significant
  6. hcup-us.ahrq.gov/reports/SASpecUnitManuscriptHCUP083010.pdf
    August 31, 2010 - comparisons of the distribution of the characteristics between the four settings were found to be statistically … 11,195 (15,885) 10,840 (15,759) NOTE: All differences in characteristics across settings were statistically … Number of Discharges Column Percentages NOTE: All differences in characteristics across settings were statistically … NOTE: All differences in characteristics across settings were statistically signifcant at P < 0.01 Number
  7. hcup-us.ahrq.gov/db/nation/nass/2019_NASS_Introduction.pdf
    January 01, 2019 - descriptions of ambulatory surgery.13 These descriptions leave room for interpretation and result in significant
  8. hcup-us.ahrq.gov/db/nation/nass/2020_NASS_Introduction.pdf
    January 01, 2020 - descriptions of ambulatory surgery.11 These descriptions leave room for interpretation and result in significant
  9. hcup-us.ahrq.gov/db/nation/nass/NASSIntroduction2021.pdf
    April 01, 2024 - descriptions of ambulatory surgery.11 These descriptions leave room for interpretation and result in significant
  10. hcup-us.ahrq.gov/db/nation/nass/NASSIntroduction2022.pdf
    December 01, 2024 - descriptions of ambulatory surgery.11 These descriptions leave room for interpretation and result in significant
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
    July 01, 2009 - The findings of Phase 1 suggest that there are no substantial, clinically significant differences in … To evolve as a fully functional system, DARTNet requires further technical refinement and a significant … The free text found in EHRs has significant benefits for clinical research and care, as has been shown … differences across individual ODM drugs or combinations in comparison to metformin monotherapy (statisticallysignificant findings were numerous but many were of questionable clinical significance).
  12. www.ahrq.gov/sites/default/files/2024-11/kupka-report.pdf
    January 01, 2024 - Results The most frequent and significant risks (failures) in the preoperative nursing assessment process … Every ASC identified inadequate or illegible documentation and inadequate verbal reporting as significant … Conclusions and recommendations: Practice/Education/Future Research: This study identified the most significant
  13. digital.ahrq.gov/sites/default/files/docs/citation/r21hs026544-devine-final-report-2022.pdf
    January 01, 2022 - Scope Background Pharmacogenomics (PGx) offers significant potential to improve drug outcomes.1,2
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/home-based-care_research-protocol.pdf
    November 19, 2014 - The comments did not lead to significant changes; however, they identified areas that required more … This may include: o Patients for whom going outside their home for care places a significant burden … Studies rated “poor” will have significant flaws that imply biases of various types that may invalidate
  15. www.ahrq.gov/sites/default/files/publications/files/cdifftoolkit.pdf
    September 01, 2012 - have found major costs associated with C. difficile, such as longer inpatient lengths of stay, and a significantSignificant progress has been made in working to control C. difficile through targeted strategies such … For example: Your facility experienced a significant increase or spike in C. difficile rates. … looking at cases during a 3- to 6-month period, at least 30 cases will probably be needed to show a statisticallysignificant relationship between exposure to antibiotics and C. difficile.
  16. S149 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
    October 01, 2007 - ORIGINAL ARTICLE Using Propensity Scores Subclassification to Estimate Effects of Longitudinal Treatments An Example Using a New Diabetes Medication Jodi B. Segal, MD, MPH,* Michael Griswold, PhD,† Aristide Achy-Brou, MS,† Robert Herbert, BS,‡ Eric B. Bass, MD, MPH,*‡ Sydney M. Dy, MD,*‡ Anne E. Millman, MS,‡ Alber…
  17. www.ahrq.gov/sites/default/files/2024-07/stock-easton-report.pdf
    January 01, 2024 - Overall, health system leadership support was significant, clinic medication safety culture improved … between-subjects effect for clinic (F = 9.65, p < .0001) and year (F = 17.5, p < .0001), and there was a significant … 2 significantly improved in the culture of medication safety from 2004 to 2005, but there was no significant … At baseline in 2004, there were no significant differences between the three clinics, but in 2005, both … Five key process components were developed to guide medication management at every significant ambulatory
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
    February 22, 2012 - Psychological grading scales can aid in the discrimination between clinically significant and nonsignificant … Results will be considered significant at the 5 percent level.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol.pdf
    September 24, 2024 - Studies rated “high risk of bias” have significant flaws that imply biases of various types that may … permit a conclusion for the outcome of interest for that KQ (for example, when a difference is not statisticallysignificant, and the 95 percent confidence is too wide to permit a conclusion that there is no important
  20. www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - medications is not available, a pragmatic approach would be to repeat risk assessment when there is a significant … No significant differences were found with tamoxifen use on rates of deep vein thrombosis, pulmonary … No significant differences were found with raloxifene use on rates of CHD events, stroke, endometrial … vasomotor and musculoskeletal symptoms with aromatase inhibitors compared with placebo. 3 , 82-84 No significant … treatment. 12 Another study that compared anastrozole with tamoxifen in treating women with DCIS found a significant